-
Most Popular
Earnings Reports
SILK Stock Earnings: Silk Road Medical Misses EPS, Beats Revenue for Q2 2024
SILK stock results show that Silk Road Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
CYN Stock Earnings: Cyngn Beats EPS, Misses Revenue for Q2 2024
CYN stock results show that Cyngn beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
TYRA Stock Earnings: Tyra Biosciences Beats EPS for Q2 2024
TYRA stock results show that Tyra Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
SLNO Stock Earnings: Soleno Therapeutics Beats EPS for Q2 2024
SLNO stock results show that Soleno Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
MRAI Stock Earnings: Marpai Misses EPS, Beats Revenue for Q2 2024
MRAI stock results show that Marpai missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q2 2024
STAA stock results show that Staar Surgical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
KROS Stock Earnings: Keros Therapeutics Misses EPS for Q2 2024
KROS stock results show that Keros Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
CVKD Stock Earnings: Cadrenal Therapeutics Misses EPS for Q2 2024
CVKD stock results show that Cadrenal Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
SYRE Stock Earnings: Spyre Therapeutics Beats EPS for Q2 2024
SYRE stock results show that Spyre Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q2 2024
DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q2 2024
TBIO stock results show that Telesis Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
PLRX Stock Earnings: Pliant Therapeutics Misses EPS for Q2 2024
PLRX stock results show that Pliant Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
GRP-U Stock Earnings: Granite Real Estate Inc. Stapled Units, each consisting of one unit of Granite Real Estate Trust and one common share of Granite REIT Inc. Reported Results for Q2 2024
Granite Real Estate Inc. Stapled Units, each consisting of one unit of Granite Real Estate Trust and one common share of Granite REIT Inc. just reported results for the second quarter of 2024.
EE Stock Earnings: Excelerate Energy Misses EPS, Beats Revenue for Q2 2024
EE stock results show that Excelerate Energy missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
VMD Stock Earnings: Viemed Healthcare Misses EPS, Misses Revenue for Q2 2024
VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
PAAS Stock Earnings: Pan American Silver Misses EPS, Misses Revenue for Q2 2024
PAAS stock results show that Pan American Silver missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
GWRS Stock Earnings: Global Water Resources Misses EPS, Misses Revenue for Q2 2024
GWRS stock results show that Global Water Resources missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
FSM Stock Earnings: Fortuna Silver Mines Reported Results for Q2 2024
Fortuna Silver Mines just reported results for the second quarter of 2024.
